 |
|
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clin Mol Hepatol. 2016;22(2):238-240. Published online 2016 Jun 25 DOI: https://doi.org/10.3350/cmh.2016.0103
|
|
Citations to this article as recorded by
 Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
Mi Na Kim, Seong Gyu Hwang, Kyu Sung Rim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Liver International.2017; 37(12): 1788. CrossRef
|